myristic acid has been researched along with zidovudine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Hostetler, KY; van den Bosch, H; van Wijk, GM | 1 |
| Edwards, T; Goff, D; Ishaq, K; Iyer, N; Krugner-Higby, L; Kucera, LS; Kute, T; Morris-Natschke, S; Neufeld, J; Piantadosi, C | 1 |
| Bi, DZ; Deng, YH; Hu, HG; Jin, SX; Wang, J; Wang, YZ | 1 |
1 review(s) available for myristic acid and zidovudine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
3 other study(ies) available for myristic acid and zidovudine
| Article | Year |
|---|---|
Antiviral nucleoside diphosphate diglycerides: improved synthesis and facilitated purification.
Topics: Acyclovir; Antiviral Agents; Cytidine Diphosphate Diglycerides; Diglycerides; Lauric Acids; Myristic Acid; Myristic Acids; Nucleosides; Phosphatidic Acids; Zalcitabine; Zidovudine | 1992 |
Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.
Topics: Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Cell Fusion; Cell Membrane; Dideoxynucleotides; Gene Products, env; HIV Antibodies; HIV Envelope Protein gp120; HIV Envelope Protein gp160; HIV-1; Indolizines; Myristic Acid; Myristic Acids; Phospholipid Ethers; Phospholipids; Protein Precursors; Protein Processing, Post-Translational; Viral Proteins; Virion; Zidovudine | 1995 |
Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes.
Topics: Animals; Anti-HIV Agents; Disaccharides; Drug Carriers; Female; Half-Life; Injections, Intravenous; Liposomes; Magnetic Resonance Spectroscopy; Male; Myristic Acid; Particle Size; Rats; Rats, Wistar; Spectrophotometry, Infrared; Suspensions; Tissue Distribution; Zidovudine | 2005 |